ZA200108054B - C10 carbonate substituted taxanes as antitumor agents. - Google Patents

C10 carbonate substituted taxanes as antitumor agents.

Info

Publication number
ZA200108054B
ZA200108054B ZA200108054A ZA200108054A ZA200108054B ZA 200108054 B ZA200108054 B ZA 200108054B ZA 200108054 A ZA200108054 A ZA 200108054A ZA 200108054 A ZA200108054 A ZA 200108054A ZA 200108054 B ZA200108054 B ZA 200108054B
Authority
ZA
South Africa
Prior art keywords
antitumor agents
carbonate substituted
substituted taxanes
taxanes
carbonate
Prior art date
Application number
ZA200108054A
Other languages
English (en)
Inventor
Robert A Holton
Original Assignee
Univ Florida State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State Res Found filed Critical Univ Florida State Res Found
Publication of ZA200108054B publication Critical patent/ZA200108054B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Epoxy Compounds (AREA)
ZA200108054A 2000-02-02 2001-10-01 C10 carbonate substituted taxanes as antitumor agents. ZA200108054B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17968400P 2000-02-02 2000-02-02

Publications (1)

Publication Number Publication Date
ZA200108054B true ZA200108054B (en) 2003-12-01

Family

ID=22657547

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200108054A ZA200108054B (en) 2000-02-02 2001-10-01 C10 carbonate substituted taxanes as antitumor agents.
ZA200108058A ZA200108058B (en) 2000-02-02 2001-10-01 Taxane formulations having improved solubility.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200108058A ZA200108058B (en) 2000-02-02 2001-10-01 Taxane formulations having improved solubility.

Country Status (25)

Country Link
US (3) US6660866B2 (cs)
EP (1) EP1165550A1 (cs)
JP (1) JP2003522171A (cs)
KR (1) KR20010111582A (cs)
CN (1) CN1186340C (cs)
AU (1) AU782028B2 (cs)
BG (1) BG65298B1 (cs)
BR (1) BR0104779A (cs)
CA (1) CA2368151A1 (cs)
CZ (1) CZ20013405A3 (cs)
GE (1) GEP20043239B (cs)
HK (1) HK1053472A1 (cs)
HU (1) HUP0200759A3 (cs)
IL (1) IL145636A0 (cs)
MX (1) MXPA01009902A (cs)
NO (1) NO20014753L (cs)
NZ (1) NZ514074A (cs)
PL (1) PL350028A1 (cs)
RO (1) RO121269B1 (cs)
RU (1) RU2264400C2 (cs)
SK (1) SK13632001A3 (cs)
TR (1) TR200102855T1 (cs)
UA (1) UA75038C2 (cs)
WO (1) WO2001057031A1 (cs)
ZA (2) ZA200108054B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL350028A1 (en) 2000-02-02 2002-10-21 Univ Florida State Res Found C10 carbonate substituted taxanes as antitumor agents
KR20010112395A (ko) * 2000-02-02 2001-12-20 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 항종양제로서의 c7 카르보네이트 치환된 탁산
JP2003521545A (ja) * 2000-02-02 2003-07-15 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 改良された溶解性を有するタキサン製剤
US6649632B2 (en) * 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
CA2354478A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 carbonate substituted taxanes
US20030082229A1 (en) * 2001-11-01 2003-05-01 Board Of Regents, The University Of Texas Systems Parenteral chlorambucil for treatment of malignant and autoimmune disease and methods of use
PE20050693A1 (es) * 2004-02-13 2005-09-27 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
US20060189679A1 (en) * 2005-02-14 2006-08-24 Florida State University Research Foundation, Inc. C10 cyclopropyl ester substituted taxane compositions
JP2011517455A (ja) * 2008-03-31 2011-06-09 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド C(10)エチルエステルおよびc(10)シクロプロピルエステル置換タキサン

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5430160A (en) 1991-09-23 1995-07-04 Florida State University Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
US5243045A (en) 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5721268A (en) 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5350866A (en) 1991-09-23 1994-09-27 Bristol-Myers Squibb Company 10-desacetoxytaxol derivatives
US5227400A (en) 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5714513A (en) 1991-09-23 1998-02-03 Florida State University C10 taxane derivatives and pharmaceutical compositions
ES2230790T3 (es) 1992-01-15 2005-05-01 E.R. SQUIBB & SONS, INC. Procedimientos enzimaticos para la resolucion de mezclas enantiomericas de compuestos utiles como intermedios en la preparacion de taxanos.
US5272171A (en) 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US5698712A (en) 1992-03-06 1997-12-16 Indena S.P.A. Baccatine III derivatives
US5939561A (en) 1992-03-10 1999-08-17 Rhone-Poulence Rorer S.A. Process for the preparation of β-phenylisoserine and β-lactam and their analogues
FR2691460B1 (fr) 1992-05-21 1994-07-22 Rhone Poulenc Rorer Sa Nouveaux derives du taxane, leur preparation et les compositions qui les contiennent.
US5254580A (en) 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
CA2100808A1 (en) 1992-10-01 1994-04-02 Vittorio Farina Deoxy paclitaxels
FR2697752B1 (fr) 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
DE4241664C2 (de) 1992-12-04 1995-04-06 Borus Spezialverfahren Elektronisches Lebensdetektionssystem
CA2109861C (en) 1992-12-04 1999-03-16 Shu-Hui Chen 6,7-modified paclitaxels
IL107950A (en) 1992-12-15 2001-04-30 Upjohn Co b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them
CA2111527C (en) 1992-12-24 2000-07-18 Jerzy Golik Phosphonooxymethyl ethers of taxane derivatives
FR2702212B1 (fr) 1993-03-02 1995-04-07 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5703247A (en) 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
US5475011A (en) 1993-03-26 1995-12-12 The Research Foundation Of State University Of New York Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
IT1261667B (it) 1993-05-20 1996-05-29 Tassano ad attivita' antitumorale.
EP0703909B1 (en) 1993-06-11 2000-04-26 PHARMACIA & UPJOHN COMPANY Delta 6,7 -taxols antineoplastic use and pharmaceutical compositions containing them
IL109926A (en) 1993-06-15 2000-02-29 Bristol Myers Squibb Co Methods for the preparation of taxanes and microorganisms and enzymes utilized therein
TW397866B (en) 1993-07-14 2000-07-11 Bristol Myers Squibb Co Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
CA2129288C (en) 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives
US6100411A (en) * 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
AU4133096A (en) * 1994-10-28 1996-05-23 Research Foundation Of The State University Of New York, The Taxoid derivatives, their preparation and their use as antitumor agents
CA2162759A1 (en) 1994-11-17 1996-05-18 Kenji Tsujihara Baccatin derivatives and processes for preparing the same
FR2732342B1 (fr) 1995-04-03 1997-04-30 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2732968B1 (fr) 1995-04-14 1997-05-16 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US5801191A (en) * 1995-06-01 1998-09-01 Biophysica Foundation Taxoids
US5780653A (en) 1995-06-07 1998-07-14 Vivorx Pharmaceuticals, Inc. Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
CA2231837A1 (en) 1995-09-13 1997-03-20 Florida State University Radiosensitizing taxanes and their pharmaceutical preparations
FR2742751B1 (fr) 1995-12-22 1998-01-30 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2745814B1 (fr) 1996-03-06 1998-04-03 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
IL126856A0 (en) 1996-05-06 1999-09-22 Univ Florida State 1-Deoxy baccatin iii 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
JPH1045583A (ja) 1996-05-14 1998-02-17 Tanabe Seiyaku Co Ltd 医薬組成物
CN1097044C (zh) 1996-07-15 2002-12-25 亚库尔特株式会社总社 紫杉烷衍生物以及含有该衍生物的药物
US5811452A (en) 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
JP2003026673A (ja) 1999-03-05 2003-01-29 Asahi Kasei Corp 骨形成促進剤
PL350028A1 (en) 2000-02-02 2002-10-21 Univ Florida State Res Found C10 carbonate substituted taxanes as antitumor agents
IL145635A0 (en) 2000-02-02 2002-06-30 Univ Florida State Res Found Taxane formulations having improved solubility

Also Published As

Publication number Publication date
BG105964A (en) 2002-08-30
BR0104779A (pt) 2001-12-26
US7056946B2 (en) 2006-06-06
US20030114493A1 (en) 2003-06-19
US7256213B2 (en) 2007-08-14
MXPA01009902A (es) 2003-07-28
WO2001057031A1 (en) 2001-08-09
UA75038C2 (en) 2006-03-15
US20040122055A1 (en) 2004-06-24
NO20014753L (no) 2001-11-29
HK1053472A1 (en) 2003-10-24
NO20014753D0 (no) 2001-10-01
US6660866B2 (en) 2003-12-09
CZ20013405A3 (cs) 2002-03-13
US20060111401A1 (en) 2006-05-25
CN1186340C (zh) 2005-01-26
HUP0200759A3 (en) 2002-10-28
AU782028B2 (en) 2005-06-30
EP1165550A1 (en) 2002-01-02
IL145636A0 (en) 2002-06-30
TR200102855T1 (tr) 2002-06-21
AU3330101A (en) 2001-08-14
RU2264400C2 (ru) 2005-11-20
RO121269B1 (ro) 2007-02-28
CA2368151A1 (en) 2001-08-09
ZA200108058B (en) 2003-12-01
HUP0200759A2 (hu) 2002-07-29
GEP20043239B (en) 2004-05-25
JP2003522171A (ja) 2003-07-22
CN1429225A (zh) 2003-07-09
SK13632001A3 (sk) 2002-06-04
KR20010111582A (ko) 2001-12-19
PL350028A1 (en) 2002-10-21
NZ514074A (en) 2004-03-26
BG65298B1 (bg) 2007-12-28

Similar Documents

Publication Publication Date Title
MXPA01009901A (es) Taxanos sustituidos con ester en c7 como agentes antitumor.
ZA200300793B (en) Substituted-triazolopyrimidines as anticancer agents.
MXPA03007093A (es) Nueva composicion.
ZA200306531B (en) Gaming machine.
ZA200308996B (en) Gaming machine.
MXPA03009558A (es) Compuestos novedosos.
HK1049987A1 (en) Elevator.
ZA200309640B (en) Gaming machine.
EG23387A (en) Spirocyclic 3-phenyl-3-substituted 4-ketolactams and-lactones.
MXPA03009698A (es) Vacuna multivalente que comprende un antigeno vih y un antigeno vsh y/o un antigeno vph.
MXPA03007693A (es) Composicion para la piel.
MXPA03004993A (es) Composiciones de policarbonato.
MXPA03008139A (es) Fluoralcoxifenilsulfonilureas sustituidas.
HK1053472A1 (en) C10 carbonate substituted taxanes as antitumor agents.
EG23378A (en) Composition.
ZA200108051B (en) C7 carbonate substituted taxanes as antitumor agents.
ZA200308177B (en) Gaming Machine.
MXPA03003861A (es) Alquildiaminas sustituidas como inhibidores de plasmepsina o proteasas relacionadas.
MXPA01000464A (es) Composicion.
MXPA03008077A (es) Composicion humedecedora para la piel..
HUP0600302A2 (en) C10 ester substituted taxanes as antitumor agents
GB0002612D0 (en) C.m.e
ZA200309958B (en) Gaming machine.
ZA200106334B (en) C10 carbonate substituted taxanes.
HK1051197A1 (en) Novel vitamin d analogues.